Akebia Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Akebia therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Akebia Therapeutic Today - Breaking & Trending Today

Atea Pharmaceuticals (NASDAQ:AVIR) vs. Akebia Therapeutics (NASDAQ:AKBA) Critical Analysis

Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) and Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Valuation and Earnings This table compares Atea […] ....

United Kingdom , United States , News Ratings For Atea Pharmaceuticals Daily , International Gmb , Mitsubishi Tanabe Pharma Corporation , Atea Pharmaceuticals Inc , Atea Pharmaceuticals , Akebia Therapeutics Inc , Get Free Report , Akebia Therapeutics , Akebia Therapeutic , Given Akebia Therapeutic , Janssen Pharmaceutica , Atea Pharmaceuticals Daily ,

Rx Rundown: Merck, Novo Nordisk, Viking Therapeutics and more

Check out this week’s medical marketing news, dealmaking and industry chatter. ....

New Jersey , United States , San Diego , New York , Pku Golike , Invivyd Pemgarda , Johnson Opsynvi , Abbvie Elahere , Jennifer Ashton , Weber Shandwick , Astrazeneca Ultomiris , Nuvation Bio , Merck Winrevair , Regeneron Odronextamab , Landos Biopharma , National Institutes Of Health , My Health , Bristol Myers Squibb , Eton Pharmaceuticals , Novo Nordisk , Place Exchange , Bellus Health , Supreme Group , Gilead Sciences , Research Projects Agency For Health , Novo Holdings ,

U.S. FDA approves Akebia's anemia drug

The U.S. Food and Drug
Administration approved Akebia Therapeutics drug to
treat anemia caused by chronic kidney disease in dialysis
patients, the drugmaker said on Wednesday.
(Reporting by Pratik. ....

Subhranshu Sahu , Pratik Jain , Vaibhav Sadhamta , Mrinmay Dey , Drug Administration , Akebia Therapeutic ,

U.S. FDA approves Akebia's anemia drug | 1330 & 101.5 WHBL

(Reuters) - The U.S. Food and Drug Administration approved Akebia Therapeutics' drug to treat anemia caused by chronic kidney disease in dialysis patients, the drugmaker said on Wednesday. (Reporting by Pratik Jain, Vaibhav Sadhamta and Mrinmay De. ....

Pratik Jain , Subhranshu Sahu , Mrinmay Dey , Vaibhav Sadhamta , Drug Administration , Akebia Therapeutic ,

Health: US FDA approves Akebia's anaemia drug

Health: US FDA approves Akebia's anaemia drug
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United States , Ed Arce , Drug Administration , Akebia Therapeutic , Disease Prevention ,